Table 1.
Factor | Number of patients or average value | |
---|---|---|
Age | 65.3 years | |
Sex | Male | 121 |
Female | 60 | |
Body mass index (BMI) | 20.3 | |
Diabetes | (−) | 152 |
(+) | 29 | |
Hemoglobin | 11.2 mg/dL | |
Leukocyte | 3105/μL | |
Lymphocyte | 449/μL | |
Albumin | 3.59 g/dL | |
Creatinine | 0.848 mg/dL | |
Concurrent therapy | RT alone | 66 |
RT + cisplatin | 99 | |
RT + cetuximab | 16 | |
Radiation method | 3D-CRT | 161 |
IMRT | 20 | |
Total dose | 63.7 Gy | |
Use of spacer | (−) | 138 |
(+) | 43 | |
Pilocarpine hydrochloride | (−) | 146 |
(+) | 35 | |
Corticosteroid ointment | (−) | 111 |
(+) | 70 | |
Number of teeth | 15.6 | |
Number of metal teeth | 5.56 | |
Alveolar bone loss | <1/2 | 153 |
≥1/2 | 28 | |
Oral mucositis | Grade 0–2 | 125 |
Grade 3 | 56 | |
Total | 181 |
RT: radiotherapy, 3D-CRT: three-dimensional conformal radiation therapy, IMRT: intensity modulated radiation therapy.